Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001171843-25-001527
Filing Date
2025-03-18
Accepted
2025-03-18 15:36:45
Documents
69
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K xbit20241231_10k.htm   iXBRL 10-K 1061967
2 EXHIBIT 4.1 ex_787007.htm EX-4.1 45595
3 EXHIBIT 10.19 ex_787015.htm EX-10.19 94758
4 EXHIBIT 21.1 ex_787008.htm EX-21.1 3631
5 EXHIBIT 23.1 ex_787009.htm EX-23.1 2232
6 EXHIBIT 31.1 ex_787010.htm EX-31.1 9188
7 EXHIBIT 31.2 ex_787011.htm EX-31.2 9193
8 EXHIBIT 32.1 ex_787012.htm EX-32.1 3661
9 EXHIBIT 32.2 ex_787013.htm EX-32.2 3565
10 EXHIBIT 97 ex_787016.htm EX-97 12679
  Complete submission text file 0001171843-25-001527.txt   5397709

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION SCHEMA xbit-20241231.xsd EX-101.SCH 41452
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE xbit-20241231_def.xml EX-101.DEF 310640
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE xbit-20241231_lab.xml EX-101.LAB 300875
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xbit-20241231_pre.xml EX-101.PRE 346001
15 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE xbit-20241231_cal.xml EX-101.CAL 45375
72 EXTRACTED XBRL INSTANCE DOCUMENT xbit20241231_10k_htm.xml XML 679875
Mailing Address 5217 WINNEBAGO LANE AUSTIN TX 78744
Business Address 5217 WINNEBAGO LANE AUSTIN TX 78744 512-386-2900
XBiotech Inc. (Filer) CIK: 0001626878 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37347 | Film No.: 25747950
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)